Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy

NCT03630991 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Chronic Myelogenous Leukemia, BCR-ABL1 Positive
High Risk Myelodysplastic Syndrome
Myelodysplastic Syndrome
Myelodysplastic/Myeloproliferative Neoplasm
Myeloproliferative Neoplasm
Recurrent Acute Myeloid Leukemia
Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Recurrent Myelodysplastic Syndrome
Recurrent Myelodysplastic/Myeloproliferative Neoplasm
Refractory Acute Myeloid Leukemia
Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Refractory Myelodysplastic Syndrome
Secondary Acute Myeloid Leukemia
Secondary Myelodysplastic Syndrome
Very High Risk Myelodysplastic Syndrome

Interventions

DRUG: Edetate Calcium Disodium
DIETARY_SUPPLEMENT: Multivitamin
DRUG: Succimer

Sponsor

M.D. Anderson Cancer Center